Andrew Mykytsey, MD
Clinical Cardiac Electrophysiology · Wausau, WINPI 1750547378
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Abbott at 27.6% of the total. 2025 is the largest year on record at $3,087, 3.2 times the $956 reported in 2019.
Across 124 payments — averaging $104.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Cardiofocus, Inc.$2K
- Medtronic$2K
- Atricure, Inc.$2K
- Philips North America LLC$655
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$342
- plus $2K from 15 others
What the payments were for
- Travel & lodging$5,79545%
- Food & beverage$7,10455%
- Education$1091%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 38 | $3,584 |
| Cardiofocus, Inc. | 13 | $2,497 |
| Medtronic(2 entities) | 19 | $2,019 |
| Atricure, Inc. | 15 | $1,990 |
| Philips North America LLC | 7 | $655 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $342 |
| Boston Scientific | 9 | $323 |
| Bayer | 4 | $322 |
| E.r. Squibb & Sons, L.L.C. | 2 | $187 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $132 |
| Novartis | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Boehringer Ingelheim | 1 | $119 |
| Merck | 1 | $103 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Abiomed | 1 | $89 |
| Siemens Medical Solutions USA, Inc. | 1 | $87 |
| Cvrx, Inc. | 1 | $84 |
| Pfizer | 1 | $64 |
| Biotronik Inc. | 1 | $39 |
| Heartflow, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HeartLight System$2,035
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,552
- EVERA MRI XT DR SURESCAN$935
- (9520) IGT Devices Undivided$489
- AVEIR$414
- ATRICLIP LAA EXCLUSION SYSTEM$214
- VERQUVO$207
- Architect$188
- Ensite Cardiac Mapping System$142
- ENSITE$139
- CAMZYOS$135
- ARCALYST$132
- Micra$128
- ENTRESTO$125
- Kerendia$125
- FARXIGA$125
- JARDIANCE$119
- NA$118
- Adempas$116
- AURORA EV-ICD MRI SURESCAN$107
How this compares
$13,008 in reported general payments places this provider in the 55th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
See all clinical cardiac electrophysiology providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 358 | $385,368 |
| XareltoRivaroxaban | 89 | $115,471 |
| MultaqDronedarone Hcl | 66 | $99,911 |
| EntrestoSacubitril/Valsartan | 45 | $52,971 |
| JardianceEmpagliflozin | 33 | $42,936 |
| FarxigaDapagliflozin Propanediol | 11 | $8,993 |
| Flecainide Acetate | 114 | $8,562 |
| Metoprolol Succinate | 510 | $8,240 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 21 | $7,187 |
| PradaxaDabigatran Etexilate Mesylate | 16 | $5,114 |
| Amiodarone Hcl | 226 | $3,928 |
| SotalolSotalol Hcl | 113 | $3,051 |
| Dofetilide | 20 | $2,787 |
| Mexiletine Hcl | 24 | $2,320 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 66 | $1,878 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $385,368358 claims |
| NovartisEntresto | $125 | $52,97145 claims |
| Boehringer IngelheimJardiance, Pradaxa | $119 | $48,05049 claims |
| AstraZenecaFarxiga | $125 | $8,99311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
Other clinical cardiac electrophysiology in Wausau
- Danylo ZorinWausau$22K
- Kevin RistWausau$16K
- Ronnie OrtizWausau$5K
- Imran NiaziMilwaukee$1M
- Miguel LealMadison$202K
- Jodi ZilinskiMilwaukee$173K
- Sanjay DeshpandeBeloit$133K
- Divya KorpuEau Claire$94K
- Marcie BergerMilwaukee$67K
- Mohammad MortadaMilwaukee$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.